Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.52 |
| ▸ | CTSL | P07711 | 4/20 | 0.47 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 6/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4690697 | 0.89 | CTSK (0.48) | CTSKCTSLCTSSCTSBMAPK1 | |
| SCHEMBL4690689 | 0.89 | CTSK (0.48) | CTSKCTSLCTSSCTSBMAPK1 | |
| SCHEMBL5092818 | 0.87 | CTSK (0.57) | CTSKCTSLCTSSMAPK1MEN1 | |
| SCHEMBL5092831 | 0.87 | CTSK (0.57) | CTSKCTSLCTSSMAPK1MEN1 | |
| SCHEMBL5096557 | 0.86 | CTSK (0.56) | CTSKCTSLCTSSMAPK1MEN1 | |
| SCHEMBL5096549 | 0.86 | CTSK (0.56) | CTSKCTSLCTSSMAPK1MEN1 | |
| SCHEMBL4686404 | 0.84 | CTSK (0.70) | CTSKCTSLCTSSCTSBMAPK1 | |
| SCHEMBL4686405 | 0.84 | CTSK (0.70) | CTSKCTSLCTSSCTSBMAPK1 | |
| SCHEMBL6771594 | 0.83 | CTSK (0.52) | CTSKCTSLCTSSMAPK1MEN1 | |
| SCHEMBL5096430 | 0.82 | CTSK (0.51) | CTSKCTSLCTSSMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1231923-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-1229912-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1229911-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1235577-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2003-04-09 | — | — | EP | disclosed |
| EP-1235577-A2 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1231923-A1 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2002-08-21 | — | — | EP | disclosed |
| EP-1229911-A1 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-1229912-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001034565-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-17 | — | — | WO | disclosed |
| WO-2001034153-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-17 | — | — | WO | disclosed |
| WO-2001034154-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-17 | — | — | WO | disclosed |
| WO-2001034157-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-17 | — | — | WO | disclosed |